Precision is advancing the final U.S. investigational new drug (IND)-enabling toxicology studies with an anticipated IND and/or clinical trial application (CTA) filing targeted by the end of 2025 with ...

August 07, 2025 - The increasing incidence of cancer and neurological disorders is a major factor driving revenue growth in ...

At the pinnacle sits Penfolds Grange and the exceptional 2021 vintage, which is about to be released. It has drawn ...

Chronic rare diseases are becoming a major challenge for the aging population in the United States. As life expectancy rises, healthcare needs become more complex, especially for conditions that are ...